26 results
424B5
TCRX
Tscan Therapeutics Inc
17 Apr 24
Prospectus supplement for primary offering
9:58pm
foundations) and tax-qualified retirement plans;
foreign governments and international organizations;
broker-dealers and traders in securities;
U.S
424B5
TCRX
Tscan Therapeutics Inc
16 Apr 24
Prospectus supplement for primary offering
5:21pm
institutions;
tax-exempt organizations (including private foundations) and tax-qualified retirement plans;
foreign governments and international
424B5
82jlm3ab4q lu3e
26 May 23
Prospectus supplement for primary offering
8:12pm
424B5
9t8 hrhhyzfdwp
25 May 23
Prospectus supplement for primary offering
4:59pm
S-3
EX-4.4
frnbyx
9 Nov 22
Shelf registration
7:53am
S-3
EX-4.5
wthtpou xspppjlnl
9 Nov 22
Shelf registration
7:53am
8-K
EX-10.1
ob4ht4
12 Sep 22
TScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures
7:51am
DEF 14A
nq5bl8 nwm6
21 Apr 22
Definitive proxy
8:00am
10-K
iyl2 6snkgvhqy
9 Mar 22
Annual report
7:30am
424B4
xpkr8
19 Jul 21
Prospectus supplement with pricing info
7:01am
S-1/A
tr7 9s8ovzyvx8
30 Apr 21
IPO registration (amended)
5:00pm